Please enable JavaScript
Powered by Benchmark International Archives - Page 1593 of 1956 - Matribhumi Samachar English
Friday, February 06 2026 | 07:53:20 PM
Home / International (page 1593)

International

Jackpot Digital Goes Live at Chumash Casino Resort in California

Vancouver, British Columbia–(Newsfile Corp. – March 25, 2025) – Jackpot Digital Inc. (TSXV: JJ) (TSXV: JJ.WT.C) (OTCQB: JPOTF) (Frankfurt Stock Exchange: LVH3) (the “Company” or “Jackpot Digital”), a leading provider of dealerless electronic poker tables to the global gaming industry, is pleased to announce it has successfully installed two of …

Read More »

24/7 Market News: Siyata’s Core Gaming Play- Turning Trailblazer into Catalyst

Denver, Colorado–(Newsfile Corp. – March 25, 2025) – 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, publishes Siyata’s Core Gaming Play- Turning Trailblazer into Catalyst editorial, featuring Siyata Mobile’s (NASDAQ: SYTA) transformative $160 million merger with Core Gaming, an AI-driven leader …

Read More »

Canaf Reports Financial Results for Q1 2025

Vancouver, British Columbia–(Newsfile Corp. – March 25, 2025) – Canaf Investments Inc. (TSXV: CAF) (“Canaf”) the Canada-registered Corporation, is pleased to announce the release of its Audited Financial Statements and Management Discussion and Analysis for the 3-month period ended January 31, 2025. Revenue for the quarter was recorded at CAN$8,344,209 (2024: …

Read More »

Waraba Gold Limited Corporate Update

Vancouver, British Columbia–(Newsfile Corp. – March 25, 2025) – Waraba Gold Limited (CSE: WBGD) (FSE: ZE0) (OTC Pink: WARAF) (the “Company” or “Waraba”) announces that: it has entered into an earn-in term sheet (the “Earn-In Term Sheet”) to acquire up to 80% of Somaco Global Resources SARL, a company incorporated …

Read More »

Kiora Pharmaceuticals Reports 2024 Results; Retinal Disease Drug Development Pipeline Continues to Advance; Cash and Short-Term Investments Expected to Fund Operations into 2027

Encinitas, California–(Newsfile Corp. – March 25, 2025) – Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) (“Kiora” or the “Company”) today announced its 2024 financial results and provided an update on its pipeline of therapeutics for the treatment of retinal diseases. Key fourth quarter and 2025 year-to-date corporate highlights include: Received approval to …

Read More »